Programmed cell death-1 inhibitor combination treatment for recurrent proficient mismatch repair/ miscrosatellite-stable type endometrial cancer: A case report

doi:10.12998/wjcc.v10.i21.7474

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 10, Issue 21

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4825)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-4) series, Tables (1-1) series.

Item

Count

PDF

240

WORD

HTML

2049

Figures (1-4)

413

Tables (1-1)

368

Sum=3125

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

215

Download

332

Sum=547

Publishing Process of This Article

Item

Count

Browse

327

Download

826

Sum=1153

Jul 26, 2022 (publication date) through Dec 22, 2024

Times Cited of This Article

Times Cited (1)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Report

World J Clin Cases. Jul 26, 2022; 10(21): 7474-7482
Published online Jul 26, 2022. doi: 10.12998/wjcc.v10.i21.7474

Full Size Figure Download Figure

Figure 3 Sum of all longest diameters for all target lesions recorded at each visit and its percentage change from baseline during programmed cell death receptor-1 inhibitor with chemotherapy or targeted therapy.

Citation: Zhai CY, Yin LX, Han WD. Programmed cell death-1 inhibitor combination treatment for recurrent proficient mismatch repair/ miscrosatellite-stable type endometrial cancer: A case report. World J Clin Cases 2022; 10(21): 7474-7482
URL: https://www.wjgnet.com/2307-8960/full/v10/i21/7474.htm
DOI: https://dx.doi.org/10.12998/wjcc.v10.i21.7474